The Ministry of Health and Ontario Health have been working together to implement evidence-based enhancements to the Ontario Cancer Screening Program (OCSP).
By increasing regular screening and follow up care for all individuals with a cervix, including women, transmasculine and non-binary individuals, better patient outcomes can be realised.
To implement this enhancement, changes to policy and claims processing have been introduced.
New policy and claims payment rules related to cervical cancer screening have been introduced.
The following policy changes are effective beginning March 3, 2025:
New tracking codes L734A and L699A have been introduced and should be used for testing under the OCSP effective March 3, 2025. Effective April 3, 2025, existing laboratory codes L713A and L733A will no longer be used for the OCSP.
Click here to read more.
